The Effects of Kegel Exercise Combined With Biofeedback Therapy on Bowel Function Recovery, Emotional Distress, and Quality of Life in Patients Following Low Anterior Resection for Rectal Cancer
BFT in LARS
Effects of Kegel Exercise Combined With a Single Biofeedback Intervention on Bowel Function, Emotional Distress, and Quality of Life in Patients After Rectal Cancer Surgery
1 other identifier
interventional
66
0 countries
N/A
Brief Summary
This randomized controlled trial aims to evaluate the effects of combining Kegel exercise with a single biofeedback session on bowel function, emotional distress, and quality of life in patients who have undergone low anterior resection (LAR) for rectal cancer. Low anterior resection syndrome (LARS) is a common postoperative complication following LAR, characterized by increased stool frequency, urgency, and incontinence, which can significantly impair patients' psychological well-being and daily quality of life. Participants will be randomly assigned to one of two groups: (1) Kegel exercise combined with one non-invasive biofeedback session, or (2) Kegel exercise alone. Both groups will perform home-based Kegel exercises for eight weeks. The study aims to determine whether the combined biofeedback and Kegel exercise intervention results in greater improvements in bowel control, emotional well-being, and quality of life compared with Kegel exercise alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedFirst Posted
Study publicly available on registry
November 28, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
November 28, 2025
October 1, 2025
1.1 years
November 19, 2025
November 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Bowel Function Measured by the Low Anterior Resection Syndrome (LARS) Score
Bowel function will be assessed using the validated Low Anterior Resection Syndrome (LARS) score, which consists of five items evaluating incontinence, frequency, clustering, and urgency. The total score ranges from 0 to 42, with higher scores indicating more severe bowel dysfunction.
Baseline, 4 weeks, 8 weeks, and 12 weeks after intervention
Secondary Outcomes (2)
Change in Emotional Distress Measured by the Hospital Anxiety and Depression Scale (HADS)
Baseline, 4 weeks, 8 weeks, and 12 weeks after intervention
The World Health Organization Quality of Life Assessment-BREF (WHOQOL-BREF)
Baseline, 4 weeks, 8 weeks, and 12 weeks after intervention
Study Arms (2)
Kegel Exercise with Biofeedback Therapy
EXPERIMENTALKegel Exercise Only
ACTIVE COMPARATORInterventions
A single 30-minute non-invasive EMG biofeedback session will guide participants to correctly contract and relax pelvic floor muscles using real-time visual and auditory feedback. Conducted by trained healthcare staff in the physical therapy center, with additional outpatient or ward instruction if needed. After the session, participants perform home-based Kegel exercises for 8 weeks (3-5 times/day, 6-8 contractions/set, hold 5-10 sec, relax 10 sec, ≥5 days/week). Research staff will follow up every 1-2 weeks by phone to monitor adherence and adjust intensity. If stable 5-sec contractions are achieved, duration or frequency may increase; if fatigue, abdominal pressure, or discomfort occurs, training will be reduced or paused for safety.
Participants in the control group will receive a single 30-minute session of verbal instruction and demonstration on Kegel exercise by trained medical personnel, without the use of any biofeedback device. The provider, setting, duration, exercise dosage, and follow-up schedule are identical to those in the experimental group.
Eligibility Criteria
You may qualify if:
- Patients who have undergone their first low anterior resection (LAR) for rectal cancer, or LAR with temporary stoma reversal at least 4 weeks prior to enrollment.
- Age ≥ 18 years.
- Hemodynamically stable with stable vital signs.
- Conscious, able to communicate in Mandarin or Taiwanese, and capable of following verbal instructions to perform exercises.
You may not qualify if:
- Presence of a current intestinal stoma.
- Implanted cardiac pacemaker.
- Scheduled to receive postoperative adjuvant radiotherapy.
- History of psychiatric disorders (e.g., depression).
- Postoperative complications such as anastomotic leakage, intra-abdominal infection, or fistula formation.
- Unable to cooperate with or complete biofeedback training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Description: Data collectors were blinded to participant group assignment to reduce potential information bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2025
First Posted
November 28, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
November 28, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share